Goldmoney (XAU.TO) traded down -1.54 % during a 24 hours period ending at 11:02 PM Central Europe on Tuesday 27th. One Goldmoney stock can currently be bought for about CAD 12.9 on popular exchanges. Current supply of Goldmoney stocks is 12.8 mn. Goldmoney has a current market capitalization of CAD 166.5 mn and approximately CAD 58.9 k worth of Goldmoney was traded on exchanges in the last 24 hours. Since last month end, Goldmoney has traded -5.26 % down. Simple moving average of last 200 days is at CAD 14.71. The highest price of past 52 weeks was recorded at CAD 19.25 on 03/04/2026. 52 weeks low was at CAD 0 on 07/10/2026.

Here is how related stocks have performed in the past 24 hours:

  • Satellos Bioscience (0IT.F) traded up 2.19 % and now trades at CAD 9.67. Satellos Bioscience has a market capitalisation of CAD 195.8 mn. Satellos Bioscience Inc. filed a Form 6‑K with the U.S. Securities and Exchange Commission on October 27 2026, announcing the creation of a Scientific Advisory Board. The board, chaired by a prominent stem‑cell researcher, includes experts from leading institutions in regenerative medicine, neuroscience, and small‑molecule chemistry. Satellos, a clinical‑stage company developing a small‑molecule therapy to enhance muscle repair, will use the board’s guidance to broaden its research into aging and neurodegenerative biology. The announcement highlights the company’s ongoing Phase 2 trials for its lead candidate in Duchenne muscular dystrophy and a recently cleared investigational new drug application for facioscapulohumeral muscular dystrophy. The filing also notes that Satellos is a foreign private issuer filing under Rule 15d‑16 and that the company remains focused on advancing regenerative biology across multiple disease areas.

  • Genesis Land Development (GDC.TO) traded flat 0 % and now trades at CAD 3.51. Genesis Land Development has a market capitalisation of CAD 197.5 mn. Genesis Land Development has a current price to earnings ratio of 6.28.

  • Cannara Biotech (LOVE.TO) traded up 0.5 % and now trades at CAD 2. Cannara Biotech has a market capitalisation of CAD 198.9 mn. Cannara Biotech has a current price to earnings ratio of 18.33.

  • American Eagle Gold (AE.V) traded down -2.08 % and now trades at CAD 0.97. Current market capitalisation for American Eagle Gold is CAD 196.9 mn.

  • Global Growth Split (GDV.TO) traded down -0.45 % and now trades at CAD 11.23. Global Growth Split has a market capitalisation of CAD 199 mn.

About Goldmoney

GoldMoney Inc. is a diversified financial service company that specializes in managing long-life assets and businesses in the real economy. The company’s main operations include precious metals custody and trading, real estate investment, and jewelry manufacturing. GoldMoney Inc. serves customers globally.